Guan S, Chen X, Chen Y, Xie W, et al. FOXM1 variant contributes to gefitinib resistance via activating wnt/beta-catenin signal pathway in non-small cell lung cancer patients. Clin Cancer Res 2022 Jun 13. pii: 704872. doi: 10.1158/1078-0432.CCR-22-0791.
PMID: 35695863